Selecta Biosciences Has Merged With Cartesian Therapeutics And Announced A $60.25M Private Financing
Portfolio Pulse from Benzinga Newsdesk
Selecta Biosciences has completed a merger with Cartesian Therapeutics and has been renamed Cartesian Therapeutics, Inc. Alongside the merger, the company announced a private financing of $60.25 million. The company's Nasdaq ticker symbol will change from SELB to RNAC effective prior to the opening of trading on November 14, 2023.
November 13, 2023 | 1:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Selecta Biosciences has merged with Cartesian Therapeutics, announced a significant private financing, and will change its ticker symbol to RNAC.
The merger and private financing are significant corporate actions that typically generate positive market sentiment, potentially leading to a short-term increase in stock price. The ticker symbol change is a direct consequence of the merger and rebranding.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100